Loading...
Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents
Outcomes for patients with multiple myeloma (MM) have improved in recent years owing to use of novel agents and high-dose therapy followed by autologous stem cell transplant (ASCT). We analyzed the outcomes of 511 consecutive patients treated with novel therapies at our institution between 2006 and...
Saved in:
| Published in: | Leukemia |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5541860/ https://ncbi.nlm.nih.gov/pubmed/27211270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.147 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|